Kyntra Bio, Inc. (KYNB)

7.075 -0.02 (-0.35%) USD  |  NASDAQ  |  Sep 18, 16:00
6.99 -0.08 (-1.20%) After-Hours: 20:00
More

Kyntra Bio Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for KYNB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Revenue Estimates for Current Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
September 17, 2026 --
September 01, 2026 --
August 31, 2026 --
August 14, 2026 --
July 06, 2026 --
June 30, 2026 --
May 12, 2026 --
March 17, 2026 --
March 16, 2026 --
December 31, 2025 --
November 11, 2025 --
October 31, 2025 --
September 30, 2025 --
September 24, 2025 --
Date Value
August 12, 2025 --
August 07, 2025 --
June 30, 2025 --
May 13, 2025 --
April 01, 2025 --
March 31, 2025 --
March 18, 2025 --
December 31, 2024 --
December 18, 2024 --
December 17, 2024 --
November 13, 2024 --
August 09, 2024 --
August 07, 2024 --
July 17, 2024 --

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Vericel Corp. Upgrade
Capricor Therapeutics, Inc. Upgrade
ARS Pharmaceuticals, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade

Revenue Estimates for Current Quarter Related Metrics

Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade